MVP feels the luck of the Irish
Medical Developments International (ASX: MVP) announced this week it received final approval from the Health Products Regulatory Authority of the Republic of Ireland to market and sell its inhaled pain-relief product Penthrox. The company said the approval gives MVP’s partner in Ireland and the United Kingdom, Galen, the opportunity to sell Penthrox effective immediately. Shares in MVP jumped following the announcement, and closed up 14.6% for the week. We own MVP in the investment portfolio.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Wilson Asset Management has a track record of making a difference for shareholders and the community for 27 years and is the investment manager for nine LICs and two unlisted funds. Wilson Asset Management invests over $6 billion on behalf of more than 130,000 retail investors. Wilson Asset Management created and is the lead supporter of the Future Generation companies, the first LICs to deliver both investment and social returns.
1 topic
1 stock mentioned
Wilson Asset Management
Wilson Asset Management has a track record of making a difference for shareholders and the community for 27 years and is the investment manager for nine LICs and two unlisted funds. Wilson Asset Management invests over $6 billion on behalf of more...
Wilson Asset Management
Wilson Asset Management has a track record of making a difference for shareholders and the community for 27 years and is the investment manager for nine LICs and two unlisted funds. Wilson Asset Management invests over $6 billion on behalf of more...
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
Wisetech tanks 17% on earnings miss but margins shine
Livewire Markets
Equities
21 ASX stocks that should be on your radar
Livewire Markets